AASLD: American Association for the Study of Liver Diseases
Home | Contact Us | Log In/Out
About Us | JoinPublic Policy | Patients | Giving to AASLD | Career Center | News | Worksites | Related Societies
 

Emerging Trends Conference 
|

Emerging Trends in Liver Imaging
September 8 – 9, 2012
Emory Conference Center Hotel, Atlanta, GA

Course Directors
Jorge A. Marrero, MD; Jayant A. Talwalkar, MD, MPH; Jeffrey C. Weinreb, MD, FACR; and Claude B. Sirlin, MD

Description
The Emerging Trends Conference (ETC) is AASLD's most flexible and forward-thinking educational program -- what's happening in hepatology right now and what does it mean for the future?

This year's ETC is a clinical course on the imaging of liver diseases and tumors. Reaching across disciplines, it's a unique collaboration between expert hepatologists and radiologists that you won't find anywhere else.

Goals and Objectives

  • Delineate and appraise state-of-the-art and emerging imaging techniques that may facilitate diagnosis, management, and research
  • Identify key knowledge gaps in imaging of hepatocellular carcinoma and chronic liver disease
  • Foster interdisciplinary collaboration to advance research and clinical care

 Registration

Mail us a registration form [PDF].

 Important Documents

Fact Sheet [PDF]

 Endorsed by American College of Radiology


 Saturday, September 8

TimeFilterPresentationFilterSpeakerFilter
Session I: Assessment of Hepatic Parenchyma
Hepatic Fibrosis
Moderators: Jayant A. Talwalkar, MD, MPH and Claude B. Sirlin, MD
8:00 am
Opening Remarks
Jeffrey C. Weinreb, MD, FACR 
8:10 am
Overview of Non-invasive Measures of Hepatic Fibrosis
Jayant A. Talwalkar, MD, MPH
8:35 am
Ultrasound Elastography
Robert P. Myers, MD
9:00 am
MRI Elastography
Richard L. Ehman, MD
9:25 am
Other Imaging Techniques
Claude B. Sirlin, MD
9:50 am
Panel Discussion
10:10 am
Break
Hepatic Steatosis
Moderators: Jayant A. Talwalkar, MD, MPH and Claude B. Sirlin, MD
10:30 am
Overview of Clinical Need for Non-invasive Assesment of Steatosis
Arthur J. McCullough, MD
10:55 am
Ultrasound and Steatosis
11:20 am
MRI and Steatosis
Hero K. Hussain, MBChB
11:45 am
Advances in CT
Sanjay Saini, MD
12:10 pm
Panel Discussion
12:30 pm
Lunch
Session II: Hepatocellular Carcinoma
HCC Surveillance and Diagnosis
Moderators: Jorge A. Marrero, MD and Jeffrey C. Weinreb, MD, FACR
1:30 pm
Overview of Surveillance, Diagnosis and Staging
Jorge A. Marrero, MD
1:55 pm
Ultrasound in Surveillance
Korosh Khalili, MD
2:20 pm
Diagnosis of HCC: CT and MRI
Jeffrey C. Weinreb, MD, FACR
2:45 pm
Emerging Techniques in HCC Imaging and Contrast Agents
Hero K. Hussain, MBChB
3:10 pm
Panel Discussion
3:30 pm
Break
HCC Treatment
Moderators: Jorge A. Marrero, MD and Jeffrey C. Weinreb, MD, FACR
3:50 pm
Emerging Techniques in Interventional Treatments for HCC
Jeff H. Geschwind, MD
4:15 pm
How to Treat Early Stage HCC: Ablation, Resection or Transplant
Shawn J. Pelletier, MD
4:40 pm
CT Evaluating Response to Local Therapy in HCC
Dushyant V. Sahani, MD
5:05 pm
MRI Evaluating Response to Local Therapy in HCC
Frank H. Miller, MD
5:30 pm
Efforts to Standardized Image Reporting in HCC
Claude B. Sirlin, MD
5:40 pm
Panel Discussion

 Sunday, September 9

PresentationFilterSpeakerFilter
Session III: Biliary Tract and Other Trends
Moderators: Gregory J. Gores, MD and Hero K. Hussain, MB,ChB
8:00 am
Opening Remarks
8:05 am
Evaluation of the Biliary Tract: MRCP vs. CT?
Benjamin M. Yeh, MD
8:30 am
Imaging Diagnosis of Cholangiocarcinoma
Tae Kyoung Kim, MD
8:55 am
Imaging Tools to Determine Candidacy for Transplant for Hilar Cholangiocarcinoma
Gregory J. Gores, MD
9:20 am
Imaging Trends in Portal Hypertension and Iron
Scott B. Reeder, MD, PhD
9:50 am
Panel Discussion
10:10 am
Break
10:30 am
Update on AHRQ Recommendations Diagnosis of HCC
Adrian M. Di Bisceglie MD, FACP
10:55 am
Opportunities for Multidisciplinary Collaboration
Jayant A. Talwalkar, MD, MPH and Claude B. Sirlin, MD
11:15 am
Discussion